饮食质量对脊髓损伤患者神经性肠道功能障碍的影响
Willemijn X M Faber1,2,3, Janneke Nachtegaal2, Janneke Stolwijk4
1Spinal Cord Injury Unit, Heliomare Rehabilitation Center, Wijk aan Zee, Netherlands.
Topics in spinal cord injury rehabilitation
|February 26, 2025
概括
脊髓损伤 (SCI) 患者通常饮食质量差,以及神经性肠道功能障碍 (NBD). 许多人不知道饮食与NBD的联系,这表明需要为SCI患者提供更好的营养指导.
科学领域:
- 营养科学 营养科学
- 康复医学 康复医学 康复医学
- 胃肠病学 胃肠病学
背景情况:
- 神经性肠道功能障碍 (NBD) 影响高达95%的脊髓损伤 (SCI) 患者,严重影响生活质量.
- 饮食是NBD管理的关键因素,但其与SCI人群中的NBD的具体关系仍未得到充分研究.
研究的目的:
- 评估慢性SCI患者的饮食质量.
- 调查饮食质量,特别是纤维摄入量与NBD症状严重程度之间的潜在联系.
- 为了确定SCI患者是否认为他们的饮食习惯和NBD症状之间存在联系.
主要方法:
- 基于网络的问卷和24小时的饮食回忆被用来评估慢性SCI患者的饮食质量和摄入量.
- 评估了NBD症状严重程度.
- 与一小部分参与者进行了半结构面试,以探索他们对饮食-NBD关系的看法.
主要成果:
- 所有28名参与者都表现出NBD的症状,并报告了整体饮食质量低下.
- 在NBD严重程度组之间没有发现饮食质量的显著差异.
- 患有更严重的NBD的参与者表现出较低的蔬菜摄入量和较高的盐摄入量;近一半的受访参与者没有认识到饮食和NBD之间的联系.
结论:
- 在慢性SCI患者中,无论NBD的严重程度如何,都观察到持续低质量的饮食.
- 很大一部分参与者对饮食对他们的NBD的影响缺乏认识.
- 虽然初步,但结果表明严重的NBD与减少蔬菜/增加盐摄入量之间的潜在关联,强调需要进一步研究来完善SCI患者的营养指南.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
294
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
294
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Irritable Bowel Syndrome III: Medical and Nursing Management
137
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
137
Irritable Bowel Syndrome I: Introduction
218
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
218
Chronic Bowel Disorders: Introduction
378
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
Drugs for Treatment of Diarrhea-Predominant IBS
140
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
140


